Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Costco price target raised to $375 from $335 at Baird » 19:15
08/05/20
08/05
19:15
08/05/20
19:15
COST

Costco

$339.96 /

+0.46 (+0.14%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

08/04/20 Cleveland Research
Costco sales appeared to improve further in July, says Cleveland Research
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/30/20 MKM Partners
Costco initiated with a Neutral at MKM Partners
COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

Hot Stocks
Costco reports July total comparable sales up 13.2%, up 15.8% excluding fuel » 16:37
08/05/20
08/05
16:37
08/05/20
16:37
COST

Costco

$339.96 /

+0.46 (+0.14%)

Costco Wholesale…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

08/04/20 Cleveland Research
Costco sales appeared to improve further in July, says Cleveland Research
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/30/20 MKM Partners
Costco initiated with a Neutral at MKM Partners
COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

COST Costco
$339.96 /

+0.46 (+0.14%)

Conference/Events
Costco to host sales conference call » 15:55
08/05/20
08/05
15:55
08/05/20
15:55
COST

Costco

$338.33 /

-1.17 (-0.34%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
$338.33 /

-1.17 (-0.34%)

COST Costco
$338.33 /

-1.17 (-0.34%)

08/04/20 Cleveland Research
Costco sales appeared to improve further in July, says Cleveland Research
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/30/20 MKM Partners
Costco initiated with a Neutral at MKM Partners
COST Costco
$338.33 /

-1.17 (-0.34%)

COST Costco
$338.33 /

-1.17 (-0.34%)

COST Costco
$338.33 /

-1.17 (-0.34%)

COST Costco
$338.33 /

-1.17 (-0.34%)

Recommendations
Regeneron price target raised to $675 from $630 at Piper Sandler » 14:51
08/05/20
08/05
14:51
08/05/20
14:51
REGN

Regeneron

$632.44 /

-14.65 (-2.26%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$632.44 /

-14.65 (-2.26%)

REGN Regeneron
$632.44 /

-14.65 (-2.26%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
REGN Regeneron
$632.44 /

-14.65 (-2.26%)

  • 27
    May
REGN Regeneron
$632.44 /

-14.65 (-2.26%)

REGN Regeneron
$632.44 /

-14.65 (-2.26%)

REGN Regeneron
$632.44 /

-14.65 (-2.26%)

On The Fly
Fly Intel: Pre-market Movers » 08:57
08/05/20
08/05
08:57
08/05/20
08:57
LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

, NVAX

Novavax

$157.30 /

+1.13 (+0.72%)

, CVS

CVS Health

$64.99 /

+1.12 (+1.75%)

, REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

, TRI

Thomson Reuters

$71.02 /

+0.66 (+0.94%)

, ABC

AmerisourceBergen

$104.86 /

+0.36 (+0.34%)

, TEVA

Teva

$11.80 /

-0.385 (-3.16%)

, HZNP

Horizon Therapeutics

$61.78 /

-1.3 (-2.06%)

, DIS

Disney

$117.45 /

+1.07 (+0.92%)

, SQ

Square

$136.74 /

+1.96 (+1.45%)

, W

Wayfair

$290.80 /

+3.21 (+1.12%)

, REYN

Reynolds Consumer Products

$34.52 /

+0.11 (+0.32%)

, BYND

Beyond Meat

$142.16 /

+7.86 (+5.85%)

, NKLA

Nikola

$38.80 /

+2.33 (+6.39%)

, TWLO

Twilio

$283.39 /

-2.995 (-1.05%)

, TDOC

Teladoc

$249.11 /

+11.77 (+4.96%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
W Wayfair
$290.80 /

+3.21 (+1.12%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

SQ Square
$136.74 /

+1.96 (+1.45%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

NVAX Novavax
$157.30 /

+1.13 (+0.72%)

NKLA Nikola
$38.80 /

+2.33 (+6.39%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

CVS CVS Health
$64.99 /

+1.12 (+1.75%)

BYND Beyond Meat
$142.16 /

+7.86 (+5.85%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
NVAX Novavax
$157.30 /

+1.13 (+0.72%)

06:58 Today Cantor Fitzgerald
Novavax price target raised to $211 from $148 at Cantor Fitzgerald
06:42 Today JPMorgan
JPMorgan upgrades Novavax on potential 'best-in-class' COVID vaccine
06:38 Today Ladenburg
Ladenburg downgrades Novavax to Sell with $105 target after vaccine data
06:35 Today Ladenburg
Novavax downgraded to Sell from Neutral at Ladenburg
CVS CVS Health
$64.99 /

+1.12 (+1.75%)

07/01/20 SVB Leerink
CVS Health reinstated with a Market Perform at SVB Leerink
06/01/20 Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
05/14/20
Fly Intel: Top five analyst upgrades
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

05/06/20
Fly Intel: Top five analyst downgrades
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 TD Securities
TD downgrades Thomson Reuters on valuation following BMO upgrade
05/06/20 TD Securities
Thomson Reuters downgraded to Hold from Buy at TD Securities
ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
TEVA Teva
$11.80 /

-0.385 (-3.16%)

07/27/20 Goldman Sachs
Teva initiated with a Neutral at Goldman Sachs
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

07/31/20 Stifel
Horizon Therapeutics price target raised to $85 from $60 at Stifel
07/31/20 Morgan Stanley
Horizon Therapeutics price target raised to $70 from $50 at Morgan Stanley
07/22/20 Piper Sandler
Horizon Therapeutics price target raised to $90 from $61 at Piper Sandler
07/16/20 Guggenheim
Horizon Therapeutics price target raised to $64 from $50 at Guggenheim
DIS Disney
$117.45 /

+1.07 (+0.92%)

08:17 Today JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08:07 Today Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
07:49 Today BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
06:36 Today Guggenheim
Disney upgraded to Buy from Neutral at Guggenheim
SQ Square
$136.74 /

+1.96 (+1.45%)

08/03/20 Deutsche Bank
Square price target raised to $140 from $120 at Deutsche Bank
07/22/20 Barclays
Square price target raised to $145 from $115 at Barclays
07/14/20 Goldman Sachs
Square initiated with a Neutral at Goldman Sachs
07/09/20
Fly Intel: Top five analyst downgrades
W Wayfair
$290.80 /

+3.21 (+1.12%)

07/29/20 Credit Suisse
Wayfair price target raised to $260 from $198 at Credit Suisse
07/27/20 Wells Fargo
Wayfair price target raised to $225 from $215 at Wells Fargo
07/24/20 Piper Sandler
Wayfair price target raised to $275 from $225 at Piper Sandler
07/20/20 Goldman Sachs
Wayfair price target raised to $260 from $220 at Goldman Sachs
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

07/16/20 JPMorgan
Reynolds Consumer Products price target raised to $38 from $37 at JPMorgan
05/15/20 Citi
Reynolds Consumer Products price target raised to $41 from $33 at Citi
02/26/20 Citi
Reynolds Consumer Products initiated with a Buy at Citi
02/25/20 Evercore ISI
Reynolds Consumer Products initiated with an Outperform at Evercore ISI
BYND Beyond Meat
$142.16 /

+7.86 (+5.85%)

08:41 Today UBS
Beyond Meat price target raised to $110 from $105 at UBS
06:07 Today Piper Sandler
Piper calls Beyond Meat the Tesla of packaged food, ups price target
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Canaccord
Canaccord starts Beyond Meat at Hold on 'lofty valuation'
NKLA Nikola
$38.80 /

+2.33 (+6.39%)

08:20 Today JPMorgan
Nikola shares may fall on 'non-news' Q2 results, says JPMorgan
08/03/20 Deutsche Bank
Nikola named short-term buy ahead of results at Deutsche Bank
07/20/20 Deutsche Bank
Nikola filing may bring 'large technical selling pressure,' says Deutsche Bank
07/16/20
Fly Intel: Top five analyst initiations
TWLO Twilio
$283.39 /

-2.995 (-1.05%)

08:38 Today Wells Fargo
Twilio price target raised to $315 from $250 at Wells Fargo
07:47 Today Oppenheimer
Twilio price target raised to $300 from $245 at Oppenheimer
07:41 Today DA Davidson
Twilio price target raised to $315 from $175 at DA Davidson
06:50 Today Mizuho
Twilio price target raised to $315 from $260 at Mizuho
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
07/30/20 JPMorgan
Teladoc price target raised to $266 from $240 at JPMorgan
07/30/20 Credit Suisse
Teladoc price target raised to $225 from $165 at Credit Suisse
W Wayfair
$290.80 /

+3.21 (+1.12%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

SQ Square
$136.74 /

+1.96 (+1.45%)

REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

NVAX Novavax
$157.30 /

+1.13 (+0.72%)

NKLA Nikola
$38.80 /

+2.33 (+6.39%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

HZNP Horizon Therapeutics
$61.78 /

-1.3 (-2.06%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

CVS CVS Health
$64.99 /

+1.12 (+1.75%)

BYND Beyond Meat
$142.16 /

+7.86 (+5.85%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

  • 27
    May
  • 31
    Jan
  • 12
    Dec
W Wayfair
$290.80 /

+3.21 (+1.12%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

SQ Square
$136.74 /

+1.96 (+1.45%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

NVAX Novavax
$157.30 /

+1.13 (+0.72%)

NKLA Nikola
$38.80 /

+2.33 (+6.39%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

CVS CVS Health
$64.99 /

+1.12 (+1.75%)

BYND Beyond Meat
$142.16 /

+7.86 (+5.85%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

SQ Square
$136.74 /

+1.96 (+1.45%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

NVAX Novavax
$157.30 /

+1.13 (+0.72%)

NKLA Nikola
$38.80 /

+2.33 (+6.39%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

CVS CVS Health
$64.99 /

+1.12 (+1.75%)

BYND Beyond Meat
$142.16 /

+7.86 (+5.85%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

SQ Square
$136.74 /

+1.96 (+1.45%)

REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

NVAX Novavax
$157.30 /

+1.13 (+0.72%)

NKLA Nikola
$38.80 /

+2.33 (+6.39%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

DIS Disney
$117.45 /

+1.07 (+0.92%)

CVS CVS Health
$64.99 /

+1.12 (+1.75%)

BYND Beyond Meat
$142.16 /

+7.86 (+5.85%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

Hot Stocks
Regeneron plans to report REGN-COV2 treatment trials in September » 07:27
08/05/20
08/05
07:27
08/05/20
07:27
REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

The company said in its…

The company said in its earnings release, "Following review from the Independent Data Monitoring Committee of REGN-COV2 Phase 1 safety results, a Phase 3 trial to evaluate REGN-COV2's ability to prevent infection among uninfected people who have had close exposure to a COVID-19 patient (such as the patient's housemate) was initiated and is being run jointly with the National Institute of Allergy and Infectious Diseases. In addition, REGN-COV2 moved into the Phase 2/3 portion of two adaptive Phase 1/2/3 trials testing the cocktail's ability to treat hospitalized and non-hospitalized patients with COVID-19. The Company plans to report initial virology and biomarker results from the REGN-COV2 treatment trials in September 2020."

ShowHide Related Items >><<
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

  • 27
    May
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

Hot Stocks
Adicet Bio receives $10M product development milestone from Regeneron » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

, TORC

resTORbio

$2.59 /

+0.035 (+1.37%)

Adicet Bio announced that…

Adicet Bio announced that it has received a $10M milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals, in accordance with the terms of its strategic collaboration with Regeneron. ADI-002 is the first of Adicet Bio's allogeneic off-the-shelf gammadelta T cell product candidates to specifically target solid tumors. ADI-002 is being developed and engineered by Adicet to express a GPC3-targeting chimeric antigen receptor and IL-15.

ShowHide Related Items >><<
TORC resTORbio
$2.59 /

+0.035 (+1.37%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
TORC resTORbio
$2.59 /

+0.035 (+1.37%)

04/29/20 Evercore ISI
resTORbio upgraded to Outperform from In Line at Evercore ISI
11/15/19 Wedbush
resTORbio downgraded to Neutral from Outperform at Wedbush
11/15/19 Guggenheim
resTORbio downgraded to Neutral from Buy at Guggenheim
11/15/19 Cantor Fitzgerald
resTORbio downgraded to Neutral from Overweight at Cantor Fitzgerald
TORC resTORbio
$2.59 /

+0.035 (+1.37%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

  • 27
    May
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

Hot Stocks
Regeneron reports Q2 EYLEA U.S. net sales $1.11B vs. $1.16B last year » 06:55
08/05/20
08/05
06:55
08/05/20
06:55
REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

, SNY

Sanofi

$51.79 /

-1.42 (-2.67%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

Regeneron (REGN) said in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$51.79 /

-1.42 (-2.67%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
SNY Sanofi
$51.79 /

-1.42 (-2.67%)

07/31/20 JPMorgan
Sanofi price target raised to EUR 106 from EUR 103 at JPMorgan
07/20/20 BMO Capital
Immunic initiated with an Outperform at BMO Capital
07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
SNY Sanofi
$51.79 /

-1.42 (-2.67%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

  • 27
    May
SNY Sanofi
$51.79 /

-1.42 (-2.67%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

SNY Sanofi
$51.79 /

-1.42 (-2.67%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

SNY Sanofi
$51.79 /

-1.42 (-2.67%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

Earnings
Regeneron reports Q2 EPS $7.16, consensus $5.98 » 06:52
08/05/20
08/05
06:52
08/05/20
06:52
REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

Reports Q2 revenue…

Reports Q2 revenue $1.95B, consensus $1.74B. "I'm very proud of how the Regeneron team has continued to drive important progress for patients, despite the significant challenges of the COVID-19 pandemic," said Leonard Schleifer, M.D., Ph.D., President and CEO of Regeneron. "We have advanced REGN-COV2, our antibody cocktail for COVID-19, into late-stage clinical studies in record time and are working to ensure supply is available later this year. We are continuing to drive strong performance with our marketed medicines, including EYLEA, Dupixent, and Libtayo, while also advancing research, development, and regulatory progress across a number of therapeutic areas including cancer, Type 2 inflammatory diseases, pain, and rare diseases."

ShowHide Related Items >><<
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 Truist
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

  • 27
    May
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

Conference/Events
Costco to host sales conference call » 04:55
08/05/20
08/05
04:55
08/05/20
04:55
COST

Costco

$339.50 /

+10.25 (+3.11%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COST Costco
$339.50 /

+10.25 (+3.11%)

COST Costco
$339.50 /

+10.25 (+3.11%)

08/04/20 Cleveland Research
Costco sales appeared to improve further in July, says Cleveland Research
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/30/20 MKM Partners
Costco initiated with a Neutral at MKM Partners
COST Costco
$339.50 /

+10.25 (+3.11%)

COST Costco
$339.50 /

+10.25 (+3.11%)

COST Costco
$339.50 /

+10.25 (+3.11%)

COST Costco
$339.50 /

+10.25 (+3.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.